Bug bounty platform connecting security researchers with Web3 projects to identify and fix blockchain vulnerabilities
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Immunefi operates a bug bounty platform that enhances Web3 security by facilitating the identification and resolution of vulnerabilities in blockchain and smart contract projects. It connects security researchers with these projects, offering rewards for responsibly disclosing potential threats, thereby safeguarding digital assets and user funds.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Immunefi Management Team
Immunefi Valuations & Financials
View real-time NPM data on Immunefi stock including daily Immunefi stock price estimates, valuation history, and historical share price information. Access Immunefi financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Immunefi pricing across six independent market signals. Looking for private company due diligence data sources on Immunefi? Get in touch to learn more.
Similar Companies
like Immunefi
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Crexi
Commerce & Marketplaces
Digital platform connecting buyers and sellers in commercial real estate, providing marketplace tools and analytics for property transactions.
Doctor Anywhere
Healthcare & Life Sciences
Digital healthcare platform connecting patients to medical services through virtual consultations, in-person clinics, and medication delivery.
NEXT Energy Technologies
Climate & Sustainability
Turns building windows into transparent solar generators to produce clean onsite energy while preserving design and reducing cooling needs.
Eden Health
Healthcare & Life Sciences
Delivers seamless, data-driven healthcare by combining primary care, 24/7 telemedicine, and insurance navigation in one platform.
Vetmab Biosciences
Healthcare & Life Sciences
Develops monoclonal antibody therapies for dogs and cats, targeting chronic diseases with human-validated approaches.
PermitFlow
Enterprise Software
Automates and streamlines construction permitting with AI, handling intake, research, submission, coordination, and issuance for faster approvals.
Avenzo Therapeutics
Healthcare & Life Sciences
Advancing oncology with selective CDK inhibitors and bispecific ADCs to deliver precise, high-impact therapies for solid tumors.
The Financial Gym
FinTech
Provides personalized financial coaching and planning to help individuals budget, manage debt, and achieve long-term financial goals.
FAQ
We have answers
Immunefi stock does not trade on public stock exchanges. Immunefi stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Immunefi stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Immunefi Stock does not trade on public stock exchanges. In order to sell Immunefi shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Immunefi does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Immunefi share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Immunefi stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Immunefi stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Immunefi stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Immunefi is a private company and has not had an IPO. There is currently no Immunefi IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Immunefi IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
